Novo Nordisks semaglutide was approved for diabetes in 2017 (Ozempic)
Our results robustly confirmed the locomotor behavior phenotype in gut microbe-depleted adult mice, suggesting that the timepoint for interventions targeting the gut microbiota is crucial for behavioral outcomes in mice
Sharing the pens carries a risk of spreading or getting a serious infection, like cellulitis, hepatitis, or HIV
doi: 10.1016/j.syapm.2016.08.005 Summary Keywords type 2 diabetes (T2D), microbiota, butyrate, metabolic disease, short chain fatty acids (SCFAs) Citation Arora T and Tremaroli V (2021) Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
Most semaglutide side effects are temporary, and most people tend to only encounter them at the beginning of taking semaglutide, but some people may encounter enduring side effects